皇家华人

header-logo
GettyImages-609179959-hero
Pathology & Laboratory Medicine
Michael W. Lawlor, MD, PhD

Michael W. Lawlor, MD, PhD

Professor

Locations

  • Pathology (Pediatric)
    Children's Wisconsin

Contact Information

Biography

Dr. Lawlor received his medical degree and doctorate from Loyola University School of Medicine in Maywood, Illinois (2004). Since completing his postdoctoral research training at Boston Children's Hospital in Massachusetts in 2008, Dr. Lawlor has established clinical and research neuromuscular pathology laboratories at the 皇家华人 with a focus on the diagnosis and treatment of pediatric muscle disease. His research interests include pathological analyses for preclinical trials in animal models of X-linked myotubular myopathy, nemaline myopathy, Duchenne muscular dystrophy, and a variety of other skeletal muscle and cardiac disorders. Dr. Lawlor is currently working with multiple industry partners in support of their gene therapy programs for genetic disorders involving skeletal muscle, heart, liver, lung, and other organ systems. He is a board-certified anatomic pathologist and neuropathologist, and has directed two clinical laboratories that perform diagnostic services for skeletal muscle and nerve biopsies. Dr. Lawlor has authored six book chapters and over 100 publications in peer-reviewed scientific journals. In the summer of 2022, Dr. Lawlor spun out his academic research laboratory to establish a new commercial research laboratory, Diverge Translational Science Laboratory, outside of MCW, which is focused on continuing their work in supporting the translation of promising therapies from the preclinical through the clinical trial stages.

Publications

  • (Forseth B, Polfuss M, Brondino M, Hunter SD, Lawlor MW, Beatka MJ, Prom MJ, Eells J, Lyons JA.) J Bodyw Mov Ther. 2022 Apr;30:203-209 PMID: 35500972 SCOPUS ID: 2-s2.0-85126290657 05/03/2022

  • (Eggers M, Vannoy CH, Huang J, Purushothaman P, Brassard J, Fonck C, Meng H, Prom MJ, Lawlor MW, Cunningham J, Sadhu C, Mavilio F.) EMBO Mol Med. 2022 Jan 11;14(1):e13968 PMID: 34850579 PMCID: PMC8749482 SCOPUS ID: 2-s2.0-85120325821 12/02/2021

  • (Dowling JJ, Müller-Felber W, Smith BK, Bönnemann CG, Kuntz NL, Muntoni F, Servais L, Alfano LN, Beggs AH, Bilder DA, Blaschek A, Duong T, Graham RJ, Jain M, Lawlor MW, Lee J, Coats J, Lilien C, Lowes LP, MacBean V, Neuhaus S, Noursalehi M, Pitts T, Finlay C, Christensen S, Rafferty G, Seferian AM, Tsuchiya E, James ES, Miller W, Sepulveda B, Vila MC, Prasad S, Rico S, Shieh PB, INCEPTUS investigators.) J Neuromuscul Dis. 2022;9(4):503-516 PMID: 35694931 PMCID: PMC9398079 SCOPUS ID: 2-s2.0-85133659377 06/14/2022

  • (Forseth B, Polfuss M, Brondino M, Hunter SD, Lawlor MW, Beatka MJ, Prom MJ, Eells J, Lyons JA.) Journal of Bodywork and Movement Therapies. April 2022;30:203-209 SCOPUS ID: 2-s2.0-85126290657 04/01/2022

  • (Gartz M, Haberman M, Prom MJ, Beatka MJ, Strande JL, Lawlor MW.) J Cardiovasc Pharmacol Ther. 2022;27:10742484221088655 PMID: 35353647 SCOPUS ID: 2-s2.0-85127284016 03/31/2022

  • (Eggers M, Vannoy CH, Huang J, Purushothaman P, Brassard J, Fonck C, Meng H, Prom MJ, Lawlor MW, Cunningham J, Sadhu C, Mavilio F.) EMBO Molecular Medicine. 11 January 2022;14(1) SCOPUS ID: 2-s2.0-85120325821 01/11/2022

  • (Molera C, Sarishvili T, Nascimento A, Rtskhiladze I, Muñoz Bartolo G, Fernández Cebrián S, Valverde Fernández J, Muñoz Cabello B, Graham RJ, Miller W, Sepulveda B, Kamath BM, Meng H, Lawlor MW.) J Neuromuscul Dis. 2022;9(1):73-82 PMID: 34366366 PMCID: PMC8842755 SCOPUS ID: 2-s2.0-85122787622 08/10/2021

  • (Hamm SE, Fathalikhani DD, Bukovec KE, Addington AK, Zhang H, Perry JB, McMillan RP, Lawlor MW, Prom MJ, Vanden Avond MA, Kumar SN, Coleman KE, Dupont JB, Mack DL, Brown DA, Morris CA, Gonzalez JP, Grange RW.) Mol Ther Methods Clin Dev. 2021 Dec 10;23:460 PMID: 34820472 PMCID: PMC8585580 11/26/2021

  • (Gartz M, Beatka M, Prom MJ, Strande JL, Lawlor MW.) Hum Mol Genet. 2021 Nov 16;30(23):2347-2361 PMID: 34270708 PMCID: PMC8600005 SCOPUS ID: 2-s2.0-85121129104 07/17/2021

  • (Lawlor MW, Dowling JJ.) Neuromuscul Disord. 2021 Oct;31(10):1004-1012 PMID: 34736623 SCOPUS ID: 2-s2.0-85118478299 11/06/2021

  • (Sullivan RT, Lam NT, Haberman M, Beatka MJ, Afzal MZ, Lawlor MW, Strande JL.) BMC Cardiovascular Disorders. December 2021;21(1) SCOPUS ID: 2-s2.0-85107953538 12/01/2021

  • (Li N, Parkes JE, Spathis R, Morales M, Mcdonald J, Kendra RM, Ott EM, Brown KJ, Lawlor MW, Nagaraju K.) J Neuromuscul Dis. 2021;8(s2):S325-S340 PMID: 34569971 SCOPUS ID: 2-s2.0-85120957320 09/28/2021

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.